Welcome to Acta Pharmacologica Sinica
APS, China's leading journal in pharmacology, encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.
Free online issue
Volume 30, No 7
July 2009
ISSN: 1671-4083
EISSN: 1745-7254
2008 impact factor 1.676*
46/125 (Chemistry, Multidisciplinary)
140/216 (Pharmacology & Pharmacy)
Editor-in-Chief:
Jian Ding
* Journal Citation Reports, Thomson Reuters 2009
FEATURED ARTICLES
REVIEW
Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment FREEORIGINAL ARTICLE
RNA interference-mediated downregulation of Beclin1 attenuates cerebral ischemic injury in rats FREEORIGINAL ARTICLE
The peroxisome proliferator-activated receptor-
(PPAR-) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats
FREE NEWS
Spanning a range of topics from bioengineering to neuropharmacology, cardiovascular pharmacology, cancer chemoprevention research and calcium signaling, APS is proud to present a collection of top review articles from recent years, as chosen by the editor. Complementing this collection, the January issue also includes the latest reviews covering various aspects of pharmacology.
From January 2009, Nature Publishing Group begins publishing APS, China's leading journal in pharmacology, in association with the Shanghai Institute of Materia Medica.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
